Variable | Category/term | Odds ratio (95% CI) | P-value |
---|---|---|---|
Model 1 | Â | Â | Â |
ACE/ARB | No | 1 | <0.001 |
 | Yes | 1.93 (1.81, 2.06) |  |
Model 2 | Â | Â | Â |
ACE/ARB | No | 1 | <0.001 |
 | Yes | 1.69 (1.58, 1.81) |  |
Age (*) | Linear term | 0.41 (0.35, 0.48) | <0.001 |
 | Quadratic term | 1.12 (1.10, 1.13) |  |
Sex | Female | 1 | <0.001 |
 | Male | 1.70 (1.58, 1.83) |  |
Model 3 | Â | Â | Â |
ACE/ARB | No | 1 | <0.001 |
 | Yes | 1.17 (1.09, 1.25) |  |
Age (*) | Linear term | 0.48 (0.42, 0.56) | <0.001 |
 | Quadratic term | 1.08 (1.07, 1.09) |  |
Sex | Female | 1 | <0.001 |
 | Male | 1.61 (1.450, 1.72) |  |
Hypertension | Â | 1.30 (1.17, 1.44) | <0.001 |
Diabetes | Â | 1.47 (1.37, 1.58) | <0.001 |
IHD | Â | 1.24 (1.16, 1.35) | 0.001 |
Heart Failure | Â | 2.29 (2.04, 2.56) | <0.001 |
Systolic BP < 100 |  | 2.32 (2.09, 2.58) | <0.001 |
CKD stage | 1 | 1 | <0.001 |
 | 2 | 1.90 (1.76, 2.04) |  |
 | 3 | 3.79 (3.46, 4.14) |  |
 | 4 | 6.79 (5.93, 7.77) |  |
Diuretic | Â | 1.42 (1.34, 1.51) | <0.001 |
Model 4 | Â | Â | Â |
ACE/ARB | No | 1 | 0.01 |
 | Yes | 1.11 (1.02, 1.20) |  |
Age (*) | Linear term | 0.69 (0.55, 0.87) | <0.001 |
 | Quadratic term | 1.05 (1.03, 1.06) |  |
Sex | Female | 1 | <0.001 |
 | Male | 1.51 (1.40, 1.64) |  |
Hypertension | Â | 1.36 (1.18, 1.56) | <0.001 |
Diabetes | Â | 1.13 (1.04, 1.23) | 0.004 |
IHD | Â | 1.28 (1.17, 1.40) | <0.001 |
Heart Failure | Â | 2.10 (1.85, 2.38) | <0.001 |
Systolic BP < 100 |  | 2.28 (2.01, 2.59) | <0.001 |
CKD stage | 1 | 1 | <0.001 |
 | 2 | 1.82 (1.67, 1.99) |  |
 | 3 | 3.40 (3.06, 3.77) |  |
 | 4 | 5.12 (4.38, 5.99) |  |
Diuretic | Â | 1.45 (1.35, 1.56) | <0.001 |
Proteinuria | None | 1 | <0.001 |
 | Moderate | 1.83 (1.69, 1.99) |  |
 | Severe | 3.27 (2.87, 3.72) |  |